Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Subpotent Eye Solution Recalled
09/21/2023
Jolynn Tumolo
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries...
09/21/2023
Pharmacy Learning Network
News
RSV's Seasonal Comeback: Tracking the Return of RSV
09/18/2023

Danielle Sposato

Danielle Sposato
The COVID-19 pandemic interrupted the usual seasonal cycles of respiratory syncytial virus (RSV) in the US. Still, as of the 2022 and 2023 fall and winter seasons, a return to pre-pandemic patterns has been observed, signaling the resurgence...
The COVID-19 pandemic interrupted the usual seasonal cycles of respiratory syncytial virus (RSV) in the US. Still, as of the 2022 and 2023 fall and winter seasons, a return to pre-pandemic patterns has been observed, signaling the resurgence...
The COVID-19 pandemic...
09/18/2023
Pharmacy Learning Network
News
The Emerging Threat of Polysubstance Use in the US
09/18/2023

Danielle Sposato

Danielle Sposato
The US faces a severe opioid crisis characterized by rising opioid use and a high fatality rate from opioid and heroin overdoses, driven by expanded opioid prescriptions, potent synthetic opioids like fentanyl, and worsening mental health...
The US faces a severe opioid crisis characterized by rising opioid use and a high fatality rate from opioid and heroin overdoses, driven by expanded opioid prescriptions, potent synthetic opioids like fentanyl, and worsening mental health...
The US faces a severe opioid...
09/18/2023
Pharmacy Learning Network

Advertisement

News
Why the CDC Has Recommended New Covid Boosters for All
09/15/2023

Arthur Allen, KFF Health News

Arthur Allen, KFF Health News
As COVID-19 hospitalizations tick upward with fall approaching, the CDC says it’s time for new boosters, and not only for those at highest risk of serious disease. Here are seven things you need to know.
As COVID-19 hospitalizations tick upward with fall approaching, the CDC says it’s time for new boosters, and not only for those at highest risk of serious disease. Here are seven things you need to know.
As COVID-19 hospitalizations...
09/15/2023
Pharmacy Learning Network
News
Overdose Fatalities Higher Than Predicted During Pandemic’s First Year
09/14/2023
Jolynn Tumolo
Drug overdose deaths increased significantly across the US during the first year of the COVID-19 pandemic, according to a study published online in PLOS Global Public Health.
Drug overdose deaths increased significantly across the US during the first year of the COVID-19 pandemic, according to a study published online in PLOS Global Public Health.
Drug overdose deaths increased...
09/14/2023
Pharmacy Learning Network
News
Baricitinib, Upadacitinib May Not Pose Same Cardiovascular Risk as Tofacitinib
09/14/2023
Jolynn Tumolo
Cardiovascular risks associated with tofacitinib may not extend to the Janus kinase (JAK) inhibitors baricitinib and upadacitinib, according to a paper published in the journal Clinical Rheumatology.
Cardiovascular risks associated with tofacitinib may not extend to the Janus kinase (JAK) inhibitors baricitinib and upadacitinib, according to a paper published in the journal Clinical Rheumatology.
Cardiovascular risks associated...
09/14/2023
Pharmacy Learning Network

Advertisement

News
Ranitidine Recalls Affected Hundreds of Thousand of Patients in US, Canada
09/14/2023
Jolynn Tumolo
The ranitidine shortage, prompted by a nitrosamine impurity detected in September 2019 that led to recalls of the drug in the United States and Canada.
The ranitidine shortage, prompted by a nitrosamine impurity detected in September 2019 that led to recalls of the drug in the United States and Canada.
The ranitidine shortage,...
09/14/2023
Pharmacy Learning Network
News
Uncovering the Complexity of US Cancer Drug Pricing
09/13/2023

Danielle Sposato

Danielle Sposato
While drug prices have been a contentious issue for years, the pricing of supplemental indications—additional uses for already-approved drugs—remains relatively unexamined.
While drug prices have been a contentious issue for years, the pricing of supplemental indications—additional uses for already-approved drugs—remains relatively unexamined.
While drug prices have been a...
09/13/2023
Pharmacy Learning Network
News
Anticonvulsant Recalled
09/08/2023
Jolynn Tumolo
A recall due to cross contamination has been issued for cartons of vigabatrin distributed throughout the United States.
A recall due to cross contamination has been issued for cartons of vigabatrin distributed throughout the United States.
A recall due to cross...
09/08/2023
Pharmacy Learning Network

Advertisement

News
Acne Medication Recalled
09/08/2023
Jolynn Tumolo
A recall for more than 11,000 bottles of clindamycin phosphate topical solution because of a container defect causing leakage.
A recall for more than 11,000 bottles of clindamycin phosphate topical solution because of a container defect causing leakage.
A recall for more than 11,000...
09/08/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use